Erika Hamilton, MD, FASCO

Sarah Cannon Research Institute

Latest Content

Key updates from ESMO Breast Cancer 2026, featuring Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Erika Hamilton discussing recent advances in breast cancer trials.

Breast Cancer

05/29/2026

Six Major Trial Updates From ESMO Breast Cancer 2026

Erika Hamilton, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD

Accelerating breast cancer treatment research by integrating Sacituzumab govitecan, Pembrolizumab, with expert clinicians Dionisia Quiroga, DO, PhD, and Erika Hamilton, MD, in Las Vegas skyline background.

TNBC

12/25/2025

SABCS 2025: Clarifying Where Sacituzumab Govitecan Fits in the Breast Cancer Treatment Landscape

Erika Hamilton, MD, FASCODionisia Quiroga, DO, PhD

ESMO 2025: SERDs, mTOR inhibitors, and VIKTORIA-1 targeted therapies for advanced breast cancer research and treatment advancements.

Breast Cancer

11/05/2025

Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

Erika Hamilton, MD, FASCOSarah Premji, MD

Updated Results from monarchE Presented at ESMO 2025, featuring Erika Hamilton, MD, FASCO, and Sarah Premji, MD, discussing recent oncology advancements.

Breast Cancer

10/31/2025

Dr. Erika Hamilton on Updated Results From monarchE Presented at ESMO 2025

Erika Hamilton, MD, FASCOSarah Premji, MD

OncUpdates breast cancer clinical trials expert panel discussing key advancements in breast cancer treatment and innovative therapies. Featuring Dr. Erika Hamilton, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Conferences

07/22/2025

5 Key Breast Cancer Clinical Trials Shaping Treatment

Erika Hamilton, MD, FASCO